Abstract
CRISPR-Cas systems have immense biotechnological utility. A recent study reveals the potential of the Cpf1 nuclease to complement and extend the existing CRISPR-Cas9 genome-editing tools.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Bacterial Proteins / genetics*
-
Bacteriophages / genetics*
-
CRISPR-Cas Systems / genetics*
-
Endodeoxyribonucleases / genetics*
-
Escherichia coli / genetics
-
Francisella / genetics
-
Genetic Engineering
-
Genome, Human*
-
Humans
-
Mutation
-
RNA Editing / genetics*
Substances
-
Bacterial Proteins
-
Endodeoxyribonucleases